Use of composite endpoints in thrombolysis trials of acute myocardial infarction

This publication has 54 references indexed in Scilit:

• TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.
  Circulation, 1993
• Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studies
  Journal of the American College of Cardiology, 1993
• Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study
  Journal of the American College of Cardiology, 1992
• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
  Circulation, 1991
• Optimizing thrombolytic therapy of acute myocardial infarction.
  Circulation, 1990
• Eligibility for intravenous thrombolysis in suspected acute myocardial infarction.
  Circulation, 1990
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
  Circulation, 1990
• Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activator
  Journal of the American College of Cardiology, 1989
• Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
  Circulation, 1989
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985